Novel Drug Solutions LLC

Eye Care Northwest, Pa

Pyp Car Northwest, Pa

Novel Drug Soultions LLC

Jeffrey T Liegner

John Scott Karolchyk

Bernard Covalesky

Richard Dilzer

Kallan Peters

Kallan Kuper

Kalian Peters

Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.

Pharmaceutical ophthalmic compositions

Pharmaceutical compositions for intraocular injection are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as triamcinolone), at least one pharmaceutically acceptable excipient and a pharmaceutically acceptable carrier. Methods for fabricating the compositions and using them for intraocular injections are also described.

Pharmaceutical compositions for intraocular administration and methods for fabricating thereof

Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof

Growing community of inventors

Boise, ID, United States of America

Jeffrey T Liegner